Back to calendar
Lyell Immunopharma, Inc. (LYEL) Earnings
LYEL reports earnings on Tuesday, November 10, 2026
earnings report
November 10, 2026 · Before Market Open
Q3 2026
Est. EPS: $-2.05
Actual EPS: $-1.92
EPS surprise: -1.05%
Company overview
Market Cap$349.2M
PriceUSD 14.25
EPS (TTM)-11.77
52-week high45.00
52-week low10.76
SectorHealth Technology
IndustryBiotechnology
Employees161